Taiwan Consensus for the Management of Cardiovascular Risks and Complications in Patients with Prostate Cancer

Area of Science:

• Oncology
• Cardiology
• Cardio-oncology

Background:

• Prostate cancer (PC) is a leading cause of cancer death in men.
• PC frequently coexists with cardiovascular disease (CVD), with rising incidence due to aging populations and increased cancer survival.
• PC treatments like androgen deprivation therapy and chemotherapy can lead to cardiovascular complications such as hypertension and heart failure.

Purpose of the Study:

• To review key issues in managing cardiovascular disease in prostate cancer patients.
• To emphasize the importance of cardio-oncology collaboration for personalized treatment planning and monitoring.
• To highlight the need for balancing cancer control with cardiovascular health.

Main Methods:

• Consensus statement review.
• Discussion of the association between CVD and PC.
• Review of screening, risk assessment, referral criteria, and management strategies for CVD in PC patients.
• Emphasis on multidisciplinary collaboration and patient education.

Main Results:

• PC treatments are associated with significant cardiovascular complications.
• Cardio-oncology collaboration is crucial for optimizing treatment outcomes.
• Personalized treatment plans and close monitoring are essential for managing coexisting PC and CVD.
• Challenges persist in screening and preventive measures.

Conclusions:

• Effective management requires a multidisciplinary approach integrating oncology and cardiology.
• Further research is needed for robust cardiovascular risk assessment tools and preventive strategies.
• Improving interdisciplinary approaches will enhance patient outcomes and reduce cardiovascular morbidity in PC patients.